NR 566 Midterm & Final Exam: Questions & Answers( Update)
Advanced Pharmacology - Care of the Family | Chamberlain
University
THIS EXAM CONTAINS:
• This document includes comprehensive practice questions and
answers designed to prepare students for the NR 566 midterm and
final exams. It covers key pharmacology concepts such as drug
classifications, mechanisms of action, side effects, patient
education, and clinical decision-making.
• The material is structured to align with typical exam content and
helps reinforce critical knowledge required for success in advanced
nursing pharmacology courses.
,NR 566 Midterm & Final Exam Study Guide
Complete 150 Questions & Answers
SECTION 1: Weight Management Pharmacology (Questions 1-12)
Question 1: What is the mechanism of action of Phentermine for weight loss?
• A) It blocks fat absorption in the intestines
• B) It is a central nervous system (CNS) stimulant that decreases appetite
• C) It increases serotonin levels to promote satiety
• D) It slows gastric emptying
Answer: B
Question 2: What is the maximum recommended duration of therapy for non-
amphetamine weight loss medications like Phentermine and Diethylpropion?
• A) 6 months
• B) 1 year
• C) 3 months or less
• D) There is no time limit
Answer: C
Question 3: Under which drug schedule are Phentermine and Diethylpropion
classified?
• A) Schedule II
• B) Schedule III
• C) Schedule IV
• D) Schedule V
,Answer: C
Question 4: Before initiating therapy with Phentermine or Diethylpropion, what
baseline labs and screening should be ordered?
• A) Lipid panel and screen for anxiety
• B) Liver function tests and screen for bipolar disorder
• C) Comprehensive Metabolic Panel (CMP) and screen for depression
• D) TSH and screen for eating disorders
Answer: C
Question 5: To help a patient avoid insomnia while taking
Phentermine/Topiramate, what specific instruction should they be given?
• A) Take the medication with a high-fat meal
• B) Take the medication at bedtime
• C) Take the medication before 16:00 (4:00 PM)
• D) Take the medication on an empty stomach first thing in the morning
Answer: C
Question 6: In which of the following conditions should Phentermine/Topiramate
be used with caution?
• A) History of drug abuse and glaucoma
• B) Hypotension and vitamin D deficiency
• C) Hypothyroidism and bradycardia
• D) Hyperlipidemia and asthma
Answer: A
, Question 7: A patient on Phentermine/Topiramate reports new-onset blurred
vision, nervousness, and anxiety. How should these be interpreted?
• A) Signs of a severe allergic reaction requiring ER referral
• B) Expected therapeutic effects indicating the medication is working
• C) Known adverse effects of Phentermine/Topiramate
• D) Symptoms of serotonin syndrome
Answer: C
Question 8: Where does Orlistat act to reduce dietary fat absorption by
approximately 30%?
• A) The liver
• B) The central nervous system
• C) The gastrointestinal tract
• D) The pancreas
Answer: C
Question 9: Patients taking Orlistat should take a multivitamin at what interval?
• A) 1 hour before or after taking Orlistat
• B) At the same time as taking Orlistat
• C) 2 hours before or after taking Orlistat
• D) Only at bedtime
Answer: C
Advanced Pharmacology - Care of the Family | Chamberlain
University
THIS EXAM CONTAINS:
• This document includes comprehensive practice questions and
answers designed to prepare students for the NR 566 midterm and
final exams. It covers key pharmacology concepts such as drug
classifications, mechanisms of action, side effects, patient
education, and clinical decision-making.
• The material is structured to align with typical exam content and
helps reinforce critical knowledge required for success in advanced
nursing pharmacology courses.
,NR 566 Midterm & Final Exam Study Guide
Complete 150 Questions & Answers
SECTION 1: Weight Management Pharmacology (Questions 1-12)
Question 1: What is the mechanism of action of Phentermine for weight loss?
• A) It blocks fat absorption in the intestines
• B) It is a central nervous system (CNS) stimulant that decreases appetite
• C) It increases serotonin levels to promote satiety
• D) It slows gastric emptying
Answer: B
Question 2: What is the maximum recommended duration of therapy for non-
amphetamine weight loss medications like Phentermine and Diethylpropion?
• A) 6 months
• B) 1 year
• C) 3 months or less
• D) There is no time limit
Answer: C
Question 3: Under which drug schedule are Phentermine and Diethylpropion
classified?
• A) Schedule II
• B) Schedule III
• C) Schedule IV
• D) Schedule V
,Answer: C
Question 4: Before initiating therapy with Phentermine or Diethylpropion, what
baseline labs and screening should be ordered?
• A) Lipid panel and screen for anxiety
• B) Liver function tests and screen for bipolar disorder
• C) Comprehensive Metabolic Panel (CMP) and screen for depression
• D) TSH and screen for eating disorders
Answer: C
Question 5: To help a patient avoid insomnia while taking
Phentermine/Topiramate, what specific instruction should they be given?
• A) Take the medication with a high-fat meal
• B) Take the medication at bedtime
• C) Take the medication before 16:00 (4:00 PM)
• D) Take the medication on an empty stomach first thing in the morning
Answer: C
Question 6: In which of the following conditions should Phentermine/Topiramate
be used with caution?
• A) History of drug abuse and glaucoma
• B) Hypotension and vitamin D deficiency
• C) Hypothyroidism and bradycardia
• D) Hyperlipidemia and asthma
Answer: A
, Question 7: A patient on Phentermine/Topiramate reports new-onset blurred
vision, nervousness, and anxiety. How should these be interpreted?
• A) Signs of a severe allergic reaction requiring ER referral
• B) Expected therapeutic effects indicating the medication is working
• C) Known adverse effects of Phentermine/Topiramate
• D) Symptoms of serotonin syndrome
Answer: C
Question 8: Where does Orlistat act to reduce dietary fat absorption by
approximately 30%?
• A) The liver
• B) The central nervous system
• C) The gastrointestinal tract
• D) The pancreas
Answer: C
Question 9: Patients taking Orlistat should take a multivitamin at what interval?
• A) 1 hour before or after taking Orlistat
• B) At the same time as taking Orlistat
• C) 2 hours before or after taking Orlistat
• D) Only at bedtime
Answer: C
